The surgical infection prevention and Surgical Care Improvement Projects: National initiatives to improve outcomes for patients having surgery

Clinical Infectious Diseases

Volumn 43, Issue 3, 2006, Pages 322-330

  Bratzler, Dale W ^a   Hunt, David R ^b  

^a Oklahoma Foundation for Medical Quality   (United States)

^b CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; DISULFIRAM; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; NEOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CARDIOVASCULAR DISEASE; COST OF ILLNESS; DRUG INDICATION; DRUG USE; HEALTH PROGRAM; HOSPITAL COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; REVIEW; SEPSIS; SURGICAL INFECTION; WOUND INFECTION;

ANTIBIOTIC PROPHYLAXIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; PROGRAM DEVELOPMENT; QUALITY OF HEALTH CARE; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 33746217384     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505220     Document Type: Review

References (60)

1. National Center for Health Statistics. Combined surgery data (NHDS and NSAS) data highlights. Available at: http://www.cdc.gov/nchs/data/hdasd/ 13_139t9.pdf. Accessed 10 January 2006.
2. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg 2004; 199:531-7.
3. Khan NA, Quan H, Bugar JM, Lemaire JB, Brant R, Ghali WA. Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med 2006; 21:177-80.
4. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? J Am Coll Surg 2003; 196:671-8.
5. Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA, Stanley JC, Upchurch GR Jr. Variation in postoperative complication rates after high-risk surgery in the United States. Surgery 2003; 134:534-40.
6. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003; 290: 1868-74.
7. Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg 1999; 230: 251-9.
8. Fleischmann KE, Goldman L, Young B, Lee TH. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med 2003; 115:515-20.
9. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg 2005; 242: 326-41.
10. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-30.
11. Centers for Medicare & Medicaid Services. Hospital quality initiatives. Available at: http://www.cms.hhs.gov/HospitalQualityInits/01_Over view.asp. Accessed 11 January 2006.
12. Surgical Infection Prevention Homepage. Available at: http://www .medqic.org/sip. Accessed 11 January 2006.
13. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706-15.
14. Gaynes R, Richards C, Edwards J, et al. Feeding back surveillance date to prevent hospital-acquired infections. Emerg Infect Dis 2001; 7:295-8.
15. Gaynes RP, Culver DH, Horan TC, et al. Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33(2 Suppl):S69-77.
16. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002; 30:458-75.
17. Jencks SF, Wilensky GR. The health care quality improvement initiative: a new approach to quality assurance in Medicare. JAMA 1992; 268: 900-4.
18. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA 2000; 284:1670-6.
19. Jencks SF, Huff ED, Guerdon T. Change in the quality of care delivered to Medicare beneficiaries 1998-1999 to 2000-2001. JAMA 2003; 289: 305-12.
20. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solumkin JS, Wittman DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993; 128:79-88.
21. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994; 18:422-7.
22. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999; 56:1839-88.
23. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-78.
24. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 2001; 43: 92-7.
25. The American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins. Antibiotic prophylaxis for gynecologic procedures. ACOG Practice Bulletin 2001; 23.
26. Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy, 2003. 33rd ed. Vermont: Antimicrobial Therapy, 2003.
27. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005; 140:174-82.
28. Dellinger EP, Hausmann SM, Bratzler DW, et al. Hospitals collaborate to decrease surgical site infections. Am J Surg 2005; 190:9-15.
29. Joint Commission on Accreditation of Healthcare Organizations. Surgical infection prevention core performance measures for national implementation. Available at: http://www.jcaho.org/pms/core+measures/ 10asipmeaslistpop.pdf. Accessed 11 January 2006.
30. US Department of Health and Human Services. Hospital compare. Available at: http://www.hospitalcompare.hhs.gov. Accessed 10 January 2006.
31. QualityNet Exchange homepage. Available at: http://qnetexchange.org. Accessed 11 January 2006.
32. University of Alabama at Birmingham Center for Outcomes and Effectiveness Research and Education. Achievable benchmarks of care. Available at: http://main.uab.edu/show.asp?durki=14527. Accessed 11 January 2006.
33. Joint Statement on the suspension of national hospital quality measure SIP-2, appropriate antibiotic selection for surgical prophylaxis. Available at: http://www.jcaho.org/pms/core+measures/sip2suspension noticecmsjcaho.pdf. Accessed 11 January 2006.
34. Chenoweth CE, DePestel DD, Prager RL. Are cephalosporins adequate for antimicrobial prophylaxis for cardiac surgery involving implants? Clin Infect Dis 2005; 41:122-4.
35. American Society of Health-System Pharmacists (ASHP). ASHP drug product shortages management resource center. Available at: http:// www.ashp.org/ shortage/index.cfm?cfid=5010084&CFToken=760098 50. Accessed 11 January 2006.
36. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277:1794-801.
37. Rubin ZA, Edwards JR, Horan TC, Jernigan JA. Staphylococcal surgical site infection following coronary artery bypass and joint replacement surgery: National Nosocomial Infections Surveillance System, 1994-2003 [abstract 42]. In: Program and abstracts of The Society for Healthcare Epidemiology of America's 15th Annual Scientific Meeting. 2005.
38. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004; 38:1364-6.
39. Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg 2006: 1:397-404. Available at: http://www.sts.org/sections/aboutthesociety/ practiceguidelines/ antibioticguideline/. Accessed 12 January 2006.
40. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101: 2916-21.
41. Surgical Care Improvement Project homepage. Available at: http:// www.medqic.org/scip. Accessed 11 January 2006.
42. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs NSQIP: the first national validated, outcome-based, risk adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998; 228:491-507.
43. Khuri SF. The NSQIP: a new frontier in surgery. Surgery 2005; 138: 837-43.
44. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National Surgical Quality Improvement Program in non-Veterans Administration hospitals: initial demonstration of feasibility. Ann Surg 2002; 236:344-53.
45. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-60.
46. Carr JM, Sellke FW, Fey M, et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg 2005; 80:902-9.
47. Alexander JW, Fischer JE, Boyajian M, Palmquist J, Morris MJ. The influence of hair-removal methods on wound infections. Arch Surg 1983; 118:347-52.
48. Kjonniksen I, Andersen BM, Sondenaa VG, Segadal L. Preoperative hair removal: a systematic literature review. AORN J 2002; 75:928-38.
49. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334:1209-15.
50. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119(1 Suppl):132S-175S.
51. Kleinbart J, Williams MV, Rask K. Prevention of venous thromboembolism. In: Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment 43. AHRQ publication no. 01-E058, July 2001. Rockville, MD: Agency for Healthcare Research and Quality, 2001. Available at http://www.ahrq.gov/ clinic/ptsafefy/chap31a.htm. Accessed 11 January 2006.
52. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism. Chest 2004; 126:3385-4005.
53. Bratzler DW, Raskob GE, Murray CK, Bumpus LJ, Piatt DS. Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting. Arch Intern Med 1998; 158:1909-12.
54. Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians Consensus Guidelines for surgical patients. Arch Intern Med 2000; 160:334-40.
55. Auerbach AD. Beta-blockers and reduction of perioperative cardiac events. In: Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment 43. AHRQ publication no. 01-E058, July 2001. Rockville, MD: Agency for Healthcare Research and Quality, 2001. Available at http://www.ahrq.gov/clinic/ ptsafery/chap25.htm. Accessed 11 January 2006.
56. Selzman CH, Miller SA, Zimmerman MA, Harken AH. The case for β-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg 2001; 136:286-90.
57. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major non-cardiac surgery. N Engl J Med 2005; 353:349-61.
58. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. Available at: http://www.acc.org/ clinical/guidelines/perio/periobetablocker.pdf. Accessed 5 April 2006.
59. Niederman MS, Craven DE, Bonten MJ, et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
60. Joint Commission on Accreditation of Healthcare Organizations. Specifications manual for national hospital quality measures-ICU (2005). Available at: http://www.jointcommission.org/PerformanceMeasure ment/MeasureReserveLibrary/Spec+Manual+-+ICU.htm. Accessed 13 June 2006.